Cowen and Company’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Cowen and Company’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,292	Closed	-$89.6K	–	783
2022 Q4	$89.6K	Buy	+7,292	New	+$174K	0.01%	218

Cowen and Company's CINC Position: Q1 2023 in Review

Cowen and Company sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 7,292 shares — an estimated $89.6K sold.

Cowen and Company first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $89.6K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Cowen and Company reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 7,292 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $89.6K.
Cowen and Company first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Cowen and Company's CinCor Pharma, Inc. Common Stock position peaked at $89.6K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.